Dr G Gautham Shenoy

Professor

Department of Pharmaceutical Chemistry

CURRENT ACADEMIC ROLE & RESPONSIBILITIES

    G Gautham Shenoy is a professor and HOD

    He:

    • Is an approved guide for PG and PhD students.
    • Involves in administrative responsibilities

 

SUBJECTS CURRENTLY TEACHING

Subject Subject code Semester
Pharmaceutical Inorganic Chemistry PD 1.5 First year PharmD
Medicinal Chemistry-I PCH 304 Third year BPharm
Medicinal Chemistry-I PCH 601 First year MPharm
Pharmaceutical Process Chemistry PCH 603 First year MPharm

ACADEMIC QUALIFICATIONS

Degree Specialisation Institute Year of passing
PhD Mangalore University 1999
MPharm Pharmaceutical Chemistry Manipal College of Pharmaceutical Sciences, Manipal 1991

Experience

Institution / Organisation Designation Role Tenure
Department of Pharmaceutics, MCOPS, Manipal Academy of Higher Education Professor 2009
Department of Pharmaceutics, MCOPS, Manipal Academy of Higher Education Associate Professor 2004
Department of Pharmaceutics, MCOPS, Manipal Academy of Higher Education Associate Professor 1993
Department of Pharmaceutics, MCOPS, Manipal Academy of Higher Education Lecturer 1991

Anti-tubercular activity

Received grants from the following funding agencies: DST, New Delhi (Co-Principal Investigator) ICMR, New Delhi (Principal Investigator) AICTE, New Delhi (Principal Investigator) DBT, New Delhi (Co- Investigator)

AREAS OF INTEREST, EXPERTISE AND RESEARCH

Area of Interest

Drug Design, Preclinical Studies

Area of Expertise

Organic Synthesis, Chromatography, In-vitro Screening Techniques for Antitubercular Activity, Physicochemical Properties.

Area of Research

Antitubercular Drug Discovery

Professional Affiliations & Contributions

  • Life Member of APTI, India, 2010.
  • Life Member of NMRS, India, 2008.

Fabrication, solid state characterization and bioavailability assessment of stable binary amorphous phases of Ritonavir with Quercetin

SJ Dengale SS Hussen BSM Krishna PB Musmade GG Shenoy KM Bhat

European Journal of Pharmaceutics and Biopharmaceutics., 2015 89, 329-338

Synthesis and Evaluation of Antitubercular Activity of Novel Diphenyl Ether Derivatives

CA Thomas SS Kar I Bairy VG Bhat VP Shenoy GG Shenoy

Indo Global Journal of Pharmaceutical Sciences. 2015, 5 (1), 19-25

Production of β-cyclodextrin from pH and thermo stable cyclodextrin glycosyl transferase, obtained from arthrobacter mysorens and its evaluation as a drug carrier for Irbesartan

Rajesh, Y Narayanan, K Srinivas Reddy M Vijaya bhaskar K Gautham G Shenoy Subramanyam VM Venkata Rao J

Current Drug Delivery, 2015, 12. pp. 1-10

In-vitro bactericidal activity of recombinant lysostaphin on biofilm producing methicillin resistant Staphylococcus aureus.

N Narasimhaswamy I Bairy A Manuel J Mathew G Shenoy L Bairy

Int. J. Curr. Microbiol. App. Sciences, 2015, 4 (1), 822-830

Preparation and characterization of co-amorphous Ritonavir–Indomethacin systems by solvent evaporation technique: Improved dissolution behavior and physical stability without evidence of intermolecular interactions.

SJ Dengale OP Ranjan SS Hussen BSM Krishna PB Musmade GG Shenoy KM Bhat

European Journal of Pharmaceutical Sciences, 2014, 62, 57-64

5-[(substituted -phenylamino)-methyl]-2-phenoxy-phenols and synthesis thereof. Indian Patent application number: 321/CHE/2015

ICMR funded project

Dr Sidharth SankarKar

Enoyl Acyl Carrier protein reeducates enzyme of Mycobacterium tuberculosis is part of type II Fatty acid synthase and is involved in the biosynthesis of mycolic acid. It is considered to be one of the ideal targets for drug discovery. Triclosan, a dipehyl ether derivative has moderate antitubercular activity. Encouraged by the outcome of the earlier work carried out in our laboratory, it was decided to explore diphenyl ethers further for antitubercular activity. In the present study, diphenyl ether derivatives have been designed with the help of docking studies and evaluated for antitubercular activity. 18 compounds had MIC ≤ 12.5 µg/mL. Few compounds possessed promising activity against Isoniazid resistant and MDR strains of Mycobacterium tuberculosis.